User profiles for Emily Higgs

Emily F Higgs

University of Chicago
Verified email at uchicago.edu
Cited by 710

[HTML][HTML] Pre-symptomatic detection of COVID-19 from smartwatch data

…, A Bahmani, A Alavi, A Celli, E Higgs… - Nature biomedical …, 2020 - nature.com
Consumer wearable devices that continuously measure vital signs have been used to monitor
the onset of infectious disease. Here, we show that data from consumer smartwatches can …

STING pathway agonism as a cancer therapeutic

BA Flood, EF Higgs, S Li, JJ Luke… - Immunological …, 2019 - Wiley Online Library
The fact that a subset of human cancers showed evidence for a spontaneous adaptive immune
response as reflected by the T cell‐inflamed tumor microenvironment phenotype led to …

[HTML][HTML] Real-time alerting system for COVID-19 and other stress events using wearable data

…, M Wang, ES Rangan, AW Brooks, Q Wang, E Higgs… - Nature medicine, 2022 - nature.com
Early detection of infectious diseases is crucial for reducing transmission and facilitating
early intervention. In this study, we built a real-time smartwatch-based alerting system that …

[HTML][HTML] Pembrolizumab plus ipilimumab following anti-PD-1/L1 failure in melanoma

…, M Velasco, J Lutzky, E Higgs… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
PURPOSE Combination of antiprogrammed cell death protein-1 (PD-1) plus anti–cytotoxic T-cell
lymphocyte-4 (anti-CTLA-4) immunotherapy shows greater response rates (RRs) than …

[HTML][HTML] Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells

JB Williams, S Li, EF Higgs, A Cabanov… - Nature …, 2020 - nature.com
PD-1/PD-L1 blockade can promote robust tumor regression yet secondary resistance often
occurs as immune selective pressure drives outgrowth of resistant tumor clones. Here using …

Mainstreaming cancer genetics: a model integrating germline BRCA testing into routine ovarian cancer clinics

…, E Dow, Y Antill, CD Wrede, O McNally, E Higgs… - Gynecologic …, 2017 - Elsevier
Objective Owing to the rapid increase in clinical need, we aimed to implement and review
the performance of a mainstreaming model of germline BRCA1/2 genetic testing in eligible …

[HTML][HTML] A scalable, secure, and interoperable platform for deep data-driven health management

…, B Rolnik, A Celli, O Dagan-Rosenfeld, E Higgs… - Nature …, 2021 - nature.com
The large amount of biomedical data derived from wearable sensors, electronic health
records, and molecular profiling (eg, genomics data) is rapidly transforming our healthcare …

COVIDOSE: a phase II clinical trial of low‐dose tocilizumab in the treatment of noncritical COVID‐19 pneumonia

…, JA Trujillo, J Yu, AJ Kacew, EF Higgs… - Clinical …, 2021 - Wiley Online Library
Interleukin‐6 (IL‐6)–mediated hyperinflammation may contribute to the mortality of coronavirus
disease 2019 (COVID‐19). The IL‐6 receptor–blocking monoclonal antibody tocilizumab …

[HTML][HTML] Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma

R Reschke, J Yu, BA Flood, EF Higgs… - … for Immunotherapy of …, 2021 - ncbi.nlm.nih.gov
AT cell-inflamed tumor microenvironment is characterized by the accumulation and local
activation of CD8+ T cells and Bat3-lineage dendritic cells, which together are associated with …

Early detection of COVID-19 using a smartwatch

…, AW Brooks, A Bahmani, A Alavi, A Celli, E Higgs… - MedRxiv, 2020 - medrxiv.org
Wearable devices digitally measuring vital signs have been used for monitoring health and
illness onset and have high potential for real-time monitoring and disease detection. As such …